Roivant Sciences Valuation
| ROIV Stock | USD 12.71 0.02 0.16% |
At this time, the company appears to be overvalued. Roivant Sciences holds a recent Real Value of $10.35 per share. The prevailing price of the company is $12.71. Our model determines the value of Roivant Sciences from analyzing the company fundamentals such as Return On Equity of 1.29, shares outstanding of 727.95 M, and Operating Margin of (74.46) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Roivant Sciences' price fluctuation is not too volatile at this time. Calculation of the real value of Roivant Sciences is based on 3 months time horizon. Increasing Roivant Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Roivant stock is determined by what a typical buyer is willing to pay for full or partial control of Roivant Sciences. Since Roivant Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roivant Stock. However, Roivant Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.71 | Real 10.35 | Hype 12.71 | Naive 13.55 |
The intrinsic value of Roivant Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Roivant Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Roivant Sciences helps investors to forecast how Roivant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roivant Sciences more accurately as focusing exclusively on Roivant Sciences' fundamentals will not take into account other important factors: Roivant Sciences Total Value Analysis
Roivant Sciences is at this time forecasted to have valuation of 3.92 B with market capitalization of 9.25 B, debt of 499.75 M, and cash on hands of 1.94 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Roivant Sciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.92 B | 9.25 B | 499.75 M | 1.94 B |
Roivant Sciences Investor Information
About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.8. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Roivant Sciences recorded earning per share (EPS) of 5.54. The entity had not issued any dividends in recent years. Based on the key indicators related to Roivant Sciences' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Roivant Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Roivant Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Roivant Sciences has an asset utilization ratio of 1.73 percent. This indicates that the Company is making $0.0173 for each dollar of assets. An increasing asset utilization means that Roivant Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Roivant Sciences Ownership Allocation
Roivant Sciences owns a total of 727.95 Million outstanding shares. The majority of Roivant Sciences outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Roivant Sciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Roivant Sciences. Please pay attention to any change in the institutional holdings of Roivant Sciences as this could imply that something significant has changed or is about to change at the company. Also note that almost sixty-four million five hundred sixty-nine thousand one hundred sixty-six invesors are currently shorting Roivant Sciences expressing very little confidence in its future performance.Roivant Sciences Profitability Analysis
The company reported the previous year's revenue of 124.8 M. Net Income was 4.23 B with loss before overhead, payroll, taxes, and interest of (477.06 M).About Roivant Sciences Valuation
Our relative valuation model uses a comparative analysis of Roivant Sciences. We calculate exposure to Roivant Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Roivant Sciences's related companies.Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people.
Roivant Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Roivant Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 831 M |
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.